NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Drop in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 32,700 shares, a decrease of 70.8% from the March 15th total of 112,100 shares. Approximately 0.8% of the company’s shares are sold short. Based on an average daily trading volume, of 199,200 shares, the short-interest ratio is presently 0.2 days.

NovaBay Pharmaceuticals Price Performance

Shares of NYSEAMERICAN NBY traded down $0.01 on Tuesday, reaching $0.55. 558 shares of the company traded hands, compared to its average volume of 913,748. NovaBay Pharmaceuticals has a fifty-two week low of $0.36 and a fifty-two week high of $9.08. The company has a market cap of $2.32 million, a P/E ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.